Traws Pharma Inc (NASDAQ:TRAW)’s traded shares stood at 0.5 million during the last session, with the company’s beta value hitting 1.04. At the close of trading, the stock’s price was $13.42, to imply an increase of 17.72% or $2.02 in intraday trading. The TRAW share’s 52-week high remains $19.94, putting it -48.58% down since that peak but still an impressive 69.75% since price per share fell to its 52-week low of $4.06. The company has a valuation of $40.60M, with an average of 2.94 million shares in intraday trading volume over the past 10 days and average of 474.93K shares over the past 3 months.

Traws Pharma Inc (NASDAQ:TRAW) trade information

After registering a 17.72% upside in the last session, Traws Pharma Inc (TRAW) has traded red over the past five days. The 5-day price performance for the stock is 151.57%, and 228.12% over 30 days. With these gigs, the year-to-date price performance is 43.99%. Short interest in Traws Pharma Inc (NASDAQ:TRAW) saw shorts transact 7389.0 shares and set a 0.62 days time to cover.

Traws Pharma Inc (TRAW) estimates and forecasts

The rating firms project that company’s revenue will grow 1.77% compared to the previous financial year.

Revenue forecast for the current quarter as set by 1 analysts is 60k. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 60k.Earnings reports from the last fiscal year show that sales brought in 56k and 56k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 7.14% before jumping 7.14% in the following quarter.

TRAW Dividends

Traws Pharma Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Traws Pharma Inc (TRAW) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 13.75 shares. This is just over 0.45% of the total shares, with a market valuation of $0.18 million. Data from the same date shows that the other fund manager holds a little less at 12.88, or 0.43% of the shares, all valued at about 0.17 million.